Accendra Health, Inc.
General ticker "ACH" information:
- Sector: Health Care
- Industry: Medical - Distribution
- Capitalization: $169.4M (TTM average)
Accendra Health, Inc. does not follow the US Stock Market performance with the rate: -16.8%.
Estimated limits based on current volatility of 14.3%: low 0.20$, high 0.27$
Factors to consider:
- Current price 89.9% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.82$, 5.56$]
- 2026-12-31 to 2027-12-31 estimated range: [2.02$, 5.72$]
Financial Metrics affecting the ACH estimates:
- Positive: with PPE of 2.9 at the end of fiscal year the price was low
- Positive: 7.45 < Operating profit margin, % of 8.03
- Positive: -1.48 < Industry operating profit margin (median), % of -0.86
- Positive: Industry inventory ratio change (median), % of -0.38 <= -0.26
- Positive: Investing cash flow per share per price, % of 68.76 > 2.40
- Positive: 3.21 < Return on assets ratio (scaled to [-100,100]) of 4.02
Short-term ACH quotes
Long-term ACH plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $10,333.97MM | $10,700.88MM | $2,762.03MM |
| Operating Expenses | $10,229.46MM | $10,908.65MM | $2,540.29MM |
| Operating Income | $104.51MM | $-207.77MM | $221.74MM |
| Non-Operating Income | $-159.23MM | $-149.59MM | $-323.69MM |
| Interest Expense | $157.91MM | $143.80MM | $107.18MM |
| Income(Loss) | $-54.73MM | $-357.36MM | $-101.95MM |
| Taxes | $-13.43MM | $5.33MM | $-0.73MM |
| Net Income(Loss)* | $-41.30MM | $-362.69MM | $-1,100.64MM |
| Stockholders Equity | $924.17MM | $565.23MM | $-460.98MM |
| Inventory | $1,110.61MM | $1,131.88MM | $74.44MM |
| Assets | $5,093.32MM | $4,656.16MM | $2,451.76MM |
| Operating Cash Flow | $740.71MM | $161.50MM | $-101.79MM |
| Capital expenditure | $207.89MM | $228.16MM | $201.32MM |
| Investing Cash Flow | $-137.25MM | $-116.53MM | $144.42MM |
| Financing Cash Flow | $-417.33MM | $-267.60MM | $188.08MM |
| Earnings Per Share** | $-0.54 | $-4.73 | $-14.31 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.